|
EEF2K expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.208400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.829200E-01 |
| Normal-vs-Stage2 |
6.912200E-01 |
| Normal-vs-Stage3 |
7.901400E-01 |
| Normal-vs-Stage4 |
8.201200E-01 |
| Stage1-vs-Stage2 |
7.380000E-01 |
| Stage1-vs-Stage3 |
6.323000E-01 |
| Stage1-vs-Stage4 |
8.700800E-01 |
| Stage2-vs-Stage3 |
5.398000E-01 |
| Stage2-vs-Stage4 |
9.013800E-01 |
| Stage3-vs-Stage4 |
6.539200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.469600E-01 |
| Normal-vs-AfricanAmerican |
6.557600E-02 |
| Normal-vs-Asian |
9.905400E-01 |
| Caucasian-vs-AfricanAmerican |
2.812200E-02 |
| Caucasian-vs-Asian |
9.506200E-01 |
| AfricanAmerican-vs-Asian |
6.843800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.009000E-01 |
| Normal-vs-Female |
7.701400E-01 |
| Male-vs-Female |
4.205000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.218600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.228200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.937800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.561700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.018200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.162200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.180560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.923400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.748380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.060200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.195400E-01 |
| Classical-VS-Follicular |
3.668400E-01 |
| Classical-VS-Other |
1.442810E-01 |
| Classical-VS-Normal |
5.772600E-01 |
| Tall-VS-Follicular |
2.338600E-01 |
| Tall-VS-Other |
8.223900E-02 |
| Tall-VS-Normal |
3.253000E-01 |
| Follicular-VS-Other |
2.042600E-01 |
| Follicular-VS-Normal |
7.898400E-01 |
| Other-VS-Normal |
1.113430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.135400E-01 |
| Normal-vs-N1 |
4.348600E-01 |
| N0-vs-N1 |
4.473600E-01 |
|
|
